4-Fluoro-3-(tetrazol-5-yl)phenylboronic acid
Product Information
Molecular Formula
C7H6BFN4O2
Molecular Weight
207.96
Description
Used in palladium-catalyzed, Suzuki-Miyuara cross coupling reactions
Synonyms
4-Fluoro-3-(1H)-tetrazol-5-yl)phenylboronic acid
IUPAC Name
[4-fluoro-3-(2H-tetrazol-5-yl)phenyl]boronic acid
SMILES
B(C1=CC(=C(C=C1)F)C2=NNN=N2)(O)O
InChI
InChI=1S/C7H6BFN4O2/c9-6-2-1-4(8(14)15)3-5(6)7-10-12-13-11-7/h1-3,14-15H,(H,10,11,12,13)
InChI Key
FELFJHZMQYCKPT-UHFFFAOYSA-N
Melting Point
163-168 °C
Flash Point
Not applicable
Safety Information
Hazards
H302
Computed Properties
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
6
Rotatable Bond Count
2
Exact Mass
208.0567838 g/mol
Monoisotopic Mass
208.0567838 g/mol
Topological Polar Surface Area
94.9Ų
Heavy Atom Count
15
Formal Charge
0
Complexity
223
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| US-10513521-B2 | Compositions and methods for inhibiting BMP | 2014-07-15 |
| US-2017197968-A1 | Compositions and Methods for Inhibiting BMP | 2014-07-15 |
| WO-2016011019-A1 | Compositions and methods for inhibiting bmp | 2014-07-15 |
| EP-2558577-A1 | Bi-functional complexes and methods for making and using such complexes | 2010-04-16 |
| US-2013281324-A1 | Bi-functinal complexes and methods for making and using such complexes | 2010-04-16 |
| WO-2011127933-A1 | Bi-functional complexes and methods for making and using such complexes | 2010-04-16 |
| CA-2659851-A1 | 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors | 2006-08-23 |
| CA-2659851-C | 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors | 2006-08-23 |
| DK-2057156-T3 | 2-METHYLMORPHOLINPYRIDO, PYRAZO AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS | 2006-08-23 |
| EP-2057156-A1 | 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors | 2006-08-23 |
